Quinazolinone compounds and derivatives thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9505749
APP PUB NO 20150225396A1
SERIAL NO

14423078

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds of Formula I are useful inhibitors of tankyrase. Compounds of Formula I have the following structure: where the definitions of the variables are provided herein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • AMGEN INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bregman, Howard Melrose, US 8 75
Buchanan, John L Newton, US 13 490
Chakka, Nagasree Lexington, US 41 484
Dimauro, Erin F Cambridge, US 20 243
Gunaydin, Hakan Somerville, US 17 55
Guzman-Perez, Angel Belmont, US 41 199
Hua, Zihao Andover, US 16 128
Huang, Xin Wellesley, US 190 686

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 29, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 29, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00